Case Comprehensive Cancer Center is among the top-rated NIH/NCI-designated cancer centers in the nation. I had been appointed as Director of Cancer Pharmacology Core (2007-2012) and as Co-Director of Translational Research & Pharmacology Core (2012-Present). In the review (October 2012) conducted by the National Cancer Institute for Cancer Center P30 grant (2 P30 CA043703-23), The Translational Research & Pharmacology Core was rated as “Excellent to Outstanding Merit”.